NCT03345979 - A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

March 12, 2019

Study Completion Date

March 12, 2019

Conditions

Schizophrenia

Interventions

COMBINATION_PRODUCT

Aripiprazole Lauroxil

Intramuscular injection; study drug provided using a pre-filled syringe

DRUG

Paliperidone Palmitate

Intramuscular injection

Trial Locations (16)

33012

Alkermes Investigational Site, Hialeah

39232

Alkermes Investigational Site, Flowood

60169

Alkermes Investigational Site, Hoffman Estates

60640

Alkermes Investigational Site, Chicago

63141

Alkermes Investigational Site, St Louis

72211

Alkermes Investigational Site, Little Rock

72758

Alkermes Investigational Site, Rogers

75042

Alkermes Investigational Site, Garland

75080

Alkermes Investigational Site, Richardson

78754

Alkermes Investigational Site, Austin

89102

Alkermes Investigational Site, Las Vegas

90230

Alkermes Investigational Site, Culver City

90703

Alkermes Investigational Site, Cerritos

91945

Alkermes Investigational Site, Lemon Grove

92845

Alkermes Investigational Site, Garden Grove

08009

Alkermes Investigational Site, Berlin